09.04.22: SPEC-SSH Course for plasma cell disorders opens for oncologists in training!

The SPEC-SSH courses (Structured Postgraduate Education Courses from the Swiss Society of Hematology) have been a major part of the hematologic training for residents in Switzerland over the last couple of years. The courses are on Saturdays, free of charge, and the feedback was thoroughly positive – organized mainly bei Prof. A. Tichelli (University Hospital Basel) and Prof. A. Rovo (Inselspital Bern). As a similar format does not yet exist for trainees in oncology, the organizers were willing to open the event for interested oncologic residents whenever hemato-oncologic topics are discussed.

On April 9th the next SPEC will take place in Bern with the topic “plasma cell disorders”. As a first attempt of a new format up to 20 oncologic trainees will be accepted. The experience of the last years shows that the content of the courses is highly relevant for written and oral exams, also in oncology. Therefore, this is a good opportunity to get an optimal preparation free of charge. Furthermore, the event is a chance to build your own network in oncology and haematology.
If you’re interested you can sign up and get more information via https://www.sgh-ssh.ch/sgh-veranstaltungen/spec-ssh/
As the number of participants is limited to 50 (30 trainees from hematology, 20 trainees from oncology) there is the “first come, first served” principal.

SOHC 2021

From 18th to 20th November 2021 the “Swiss Oncology and Hematology Congress” (SOHC) took place at the “Circle Convention Center Zurich Airport”. Among other very interesting presentations about oncology and hematology at the SOHC, two events organized by SHOOT were held.

 

First, an aperitif was offered for all interested members and guests of SHOOT on Friday evening. Then, second, the first session of SHOOT was conducted on Saturday morning, led by Friederike Vetter and Eveline Daetwyler, as co-chairs. This first session was structured into three parts and shed light on a career in oncology and hematology at three different phases: the beginning of a career (speaker: Dr. A. Condoluci), the middle phase (speaker: Prof. Dr. A. Wicki) and the end phase reached after long experience (speaker: Prof. Dr. M. Bargetzi). These presentations were very interesting and gave us various inputs to help us plan and structure our future careers. The event was very well attended, despite being held early on Saturday morning, and we received a great deal of positive feedback.

 

In summary, we achieved the goal we set ourselves: networking with other oncologists and hematologists, recruiting new members to our new organization, and gathering information for future SHOOT events. We are greatly looking forward to the next events.

 

See you soon, Eveline Daetwyler and Friederike Vetter